Amanote Research
Register
Sign In
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) in Turkey
Value in Health
- United Kingdom
doi 10.1016/j.jval.2015.03.1178
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2015
Authors
E. Erdal
H. Sayman
C. Turkmen
F. Aral
O. Yildiz
K. Okutur
E. Parali
C. Deger
A. Tunalioglu
C. Sar
S. Asan
F. Sumer
O. Ozel
Publisher
Elsevier BV
Related search
Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That Is Refractory to Radioactive Iodine (RAI) Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Systematic Review of Lenvatinib and Sorafenib for Treating Progressive, Locally Advanced or Metastatic, Differentiated Thyroid Cancer After Treatment With Radioactive Iodine
BMC Cancer
Cancer Research
Oncology
Genetics
Phase 2 Study Evaluating the Combination of Sorafenib and Temsirolimus in the Treatment of Radioactive Iodine-Refractory Thyroid Cancer
Cancer
Cancer Research
Oncology
Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Targetable Gene Fusions Identified in Radioactive Iodine-Refractory Advanced Thyroid Carcinoma
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
RECIST 1.1 and Serum Thyroglobulin Measurements in the Evaluation of Responses to Sorafenib in Patients With Radioactive Iodine‑refractory Differentiated Thyroid Carcinoma
Oncology Letters
Cancer Research
Oncology
Dietary Iodine Restriction in Preparation for Radioactive Iodine Treatment or Scanning in Well-Differentiated Thyroid Cancer: A Systematic Review
Thyroid
Medicine
Endocrinology
Metabolism
Diabetes
Transferrin Receptor-Targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Differentiated Thyroid Cancer in Pediatric Population (≤18 Years): Postoperative Treatment With Radioactive Iodine (I-131)
Acta Clinica Croatica
Medicine
